Entrada Therapeutics is a clinical-stage biopharmaceutical company developing genetic medicines for neuromuscular and inherited retinal diseases using its proprietary EEV (Endosomal Escape Vehicle) platform. The company advances EEV-PMO oligonucleotide therapeutics that promote exon skipping in Duchenne muscular dystrophy (ENTR-601-44, ENTR-601-45, ENTR-601-50, ENTR-601-51), a DM1 program (VX-670) partnered with Vertex, and ocular oligonucleotide candidates (ENTR-801) for Usher syndrome type 2A. The platform uses small cyclic peptides to enable intracellular delivery of therapeutics that engage previously inaccessible targets.
expected 2027-01-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001689375-26-000011 | EDGAR | 111K words |
| 2025-02-27 | 2024-12-31 | 0001689375-25-000011 | EDGAR | 111K words |
| 2024-03-13 | 2023-12-31 | 0001689375-24-000016 | EDGAR | 118K words |
| 2023-03-06 | 2022-12-31 | 0001689375-23-000019 | EDGAR | 113K words |
| 2022-03-15 | 2021-12-31 | 0001558370-22-003614 | EDGAR | 112K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-11-05 | 2026-09-30 | 0001689375-26-000064 | EDGAR | 76K words |
| 2026-08-05 | 2026-06-30 | 0001689375-26-000054 | EDGAR | 76K words |
| 2025-11-06 | 2025-09-30 | 0001689375-25-000050 | EDGAR | 75K words |
| 2025-08-06 | 2025-06-30 | 0001689375-25-000043 | EDGAR | 75K words |
| 2025-05-08 | 2025-03-31 | 0001689375-25-000024 | EDGAR | 73K words |
| 2024-11-05 | 2024-09-30 | 0001689375-24-000063 | EDGAR | 75K words |
| 2024-08-13 | 2024-06-30 | 0001689375-24-000047 | EDGAR | 75K words |
| 2024-05-07 | 2024-03-31 | 0001689375-24-000027 | EDGAR | 72K words |
| 2023-11-07 | 2023-09-30 | 0001689375-23-000074 | EDGAR | 78K words |
| 2023-08-08 | 2023-06-30 | 0001689375-23-000055 | EDGAR | 76K words |
| 2023-05-10 | 2023-03-31 | 0001689375-23-000039 | EDGAR | 75K words |
| 2022-11-07 | 2022-09-30 | 0001689375-22-000045 | EDGAR | 73K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-11-05 | 0001689375-26-000063 | EDGAR | 3K words |
| 2026-10-14 | 0001689375-26-000057 | EDGAR | 2K words |
| 2026-08-05 | 0001689375-26-000052 | EDGAR | 3K words |
| 2026-02-26 | 0001689375-26-000009 | EDGAR | 3K words |
| 2026-01-08 | 0001689375-26-000003 | EDGAR | 2K words |
| 2025-11-06 | 0001689375-25-000049 | EDGAR | 2K words |
| 2025-08-06 | 0001689375-25-000041 | EDGAR | 2K words |
| 2025-06-11 | 0001104659-25-058536 | EDGAR | 1K words |
| 2025-06-03 | 0001689375-25-000027 | EDGAR | 1K words |
| 2025-05-08 | 0001689375-25-000022 | EDGAR | 2K words |
81 total filings indexed. 54 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001689375 |
| Ticker | TRDA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.entradatx.com |
| Listed | 2021-10-29 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/TRDA (~200 tokens, structured JSON with cryptographic provenance)